Have your own idea? Try our Stock Screener
Italian (Borsa Italiana) Healthcare Sector Analysis
UpdatedNov 11, 2025
DataAggregated Company Financials
Companies18
- 7D-5.6%
- 3M-6.4%
- 1Y-21.4%
- YTD-18.2%
Over the last 7 days, the Healthcare industry has dropped 6.5%, driven by a pullback from DiaSorin of 23%. The industry has fallen 22% in the last year. As for the next few years, earnings are expected to grow by 12% per annum.
Sector Valuation and Performance
Has the Italian Healthcare Sector valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Tue, 11 Nov 2025 | €20.7b | €8.8b | €878.7m | 20x | 23.6x | 2.4x |
| Thu, 09 Oct 2025 | €23.0b | €8.8b | €895.5m | 20.3x | 25.7x | 2.6x |
| Sat, 06 Sep 2025 | €23.1b | €8.7b | €902.9m | 20.2x | 25.6x | 2.7x |
| Mon, 04 Aug 2025 | €22.4b | €8.7b | €909.8m | 20x | 24.6x | 2.6x |
| Wed, 02 Jul 2025 | €23.3b | €25.2b | €985.5m | 19.5x | 23.7x | 0.9x |
| Fri, 30 May 2025 | €23.0b | €25.2b | €985.5m | 19.5x | 23.4x | 0.9x |
| Sun, 27 Apr 2025 | €22.0b | €20.1b | €908.1m | 18x | 24.2x | 1.1x |
| Tue, 25 Mar 2025 | €22.9b | €19.6b | €796.9m | 21.2x | 28.7x | 1.2x |
| Thu, 20 Feb 2025 | €26.0b | €20.0b | €821.4m | 23.7x | 31.7x | 1.3x |
| Sat, 18 Jan 2025 | €25.3b | €8.0b | €834.7m | 21.5x | 30.4x | 3.2x |
| Mon, 16 Dec 2024 | €24.5b | €19.0b | €1.4b | 18.7x | 17.1x | 1.3x |
| Wed, 13 Nov 2024 | €24.7b | €19.0b | €1.4b | 18.3x | 17.3x | 1.3x |
| Fri, 11 Oct 2024 | €25.2b | €18.9b | €1.4b | 17.3x | 18.3x | 1.3x |
| Sun, 08 Sep 2024 | €25.2b | €18.9b | €1.4b | 14.4x | 18.2x | 1.3x |
| Tue, 06 Aug 2024 | €24.7b | €18.9b | €1.4b | 16.1x | 17.8x | 1.3x |
| Thu, 04 Jul 2024 | €25.9b | €18.8b | €1.4b | 16.4x | 18.7x | 1.4x |
| Sat, 01 Jun 2024 | €26.1b | €18.8b | €1.4b | 17.5x | 18.8x | 1.4x |
| Mon, 29 Apr 2024 | €25.4b | €18.7b | €1.4b | 19.3x | 18.5x | 1.4x |
| Wed, 27 Mar 2024 | €25.8b | €18.6b | €1.4b | 21x | 18.5x | 1.4x |
| Fri, 23 Feb 2024 | €25.6b | €18.6b | €1.4b | 18.7x | 18.5x | 1.4x |
| Sun, 21 Jan 2024 | €24.1b | €18.6b | €1.4b | 18.5x | 17.3x | 1.3x |
| Tue, 19 Dec 2023 | €24.7b | €18.6b | €1.4b | 18.5x | 17.7x | 1.3x |
| Thu, 16 Nov 2023 | €22.9b | €18.6b | €1.4b | 16.9x | 16.5x | 1.2x |
| Sat, 14 Oct 2023 | €22.7b | €18.6b | €1.4b | 17.2x | 15.7x | 1.2x |
| Mon, 11 Sep 2023 | €23.4b | €17.3b | €1.1b | 15.2x | 20.5x | 1.4x |
| Wed, 09 Aug 2023 | €23.5b | €7.8b | €857.9m | 17.9x | 27.4x | 3x |
| Fri, 07 Jul 2023 | €23.0b | €7.7b | €822.5m | 16.8x | 28x | 3x |
| Sun, 04 Jun 2023 | €24.2b | €7.7b | €822.5m | 21.5x | 29.4x | 3.1x |
| Tue, 02 May 2023 | €24.0b | €7.6b | €826.9m | 21.9x | 29x | 3.2x |
| Thu, 30 Mar 2023 | €23.1b | €7.5b | €823.6m | 21.8x | 28.1x | 3.1x |
| Sat, 25 Feb 2023 | €23.3b | €7.5b | €867.3m | 24.2x | 26.8x | 3.1x |
| Mon, 23 Jan 2023 | €23.9b | €7.4b | €886.1m | 23.5x | 27x | 3.2x |
| Wed, 21 Dec 2022 | €23.2b | €7.4b | €886.1m | 21.9x | 26.2x | 3.1x |
| Fri, 18 Nov 2022 | €23.8b | €7.4b | €887.3m | 21.5x | 26.8x | 3.2x |
Price to Earnings Ratio
26.8x
Current Industry PE
- Investors are relatively neutral on the Italian Healthcare industry at the moment, indicating that they anticipate long term growth rates to remain steady.
- The industry is trading close to its 3-year average PE ratio of 23.0x.
- The 3-year average PS ratio of 2.0x is lower than the industry's current PS ratio of 2.3x.
Past Earnings Growth
- The earnings for companies in the Healthcare industry have remained mostly flat over the last three years.
- Meanwhile revenues for these companies have grown 5.6% per year.
- This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased and as a result, profits have held steady.
Industry Trends
Which industries have driven the changes within the Italian Healthcare sector?
| IT Market | 1.13% | |
| Healthcare | -5.60% | |
| Healthtech | 4.24% | |
| Life Sciences | -0.86% | |
| Pharma | -1.27% | |
| Biotech | -1.74% | |
| Healthcare Services | -3.21% | |
| Medical Equipment | -16.38% | |
Industry PE
- Investors are most optimistic about the Healthtech industry even though it's trading below its 3-year average PE ratio of 55.6x.
- Analysts are expecting annual earnings growth of 24.9%, which is lower than the prior year's growth of 116.9% per year.
- Investors are most pessimistic about the Life Sciences industry, which is trading below its 3-year average of 32.0x.
Forecasted Growth
- Analysts are most optimistic on the Healthtech industry, expecting annual earnings growth of 25% over the next 5 years.
- However this is lower than its past earnings growth rate of 117% per year.
- In contrast, the Biotech industry is expected to see its earnings decline by 76% per year over the next few years.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| GPI GPI | €17.70 | 4.2% +€20.8m | 49.5% | PE32.2x | |
| HI Health Italia | €287.00 | 0.7% +€374.0k | 135.2% | PE17.4x |
